Current through Register Vol. XLI, No. 50, December 13, 2024
Section 15-2-9 - Miscellaneous9.1. Distribution upon discontinuance or transfer of business. 9.1.1. Any registrant desiring to discontinue or transfer business activities altogether or with respect to controlled substances shall notify the Board immediately and shall submit with the notification a complete and detailed closing inventory of all controlled substances in the registrant's possession.9.2. Disposal of controlled substances. 9.2.1. Compliance with federal law and regulations is considered in compliance with this section. A registrant shall document the destruction or disposal of all controlled substances on the appropriate form approved by the Board. The disposal of excessive amounts of residual and wasted controlled substances accrued by extemporaneous compounding in an institutional setting may be completed by two registered or licensed health care professionals with a record of the destruction indicating the two witnesses with their signatures.9.2.2. Registrants may become registered with the DEA as an authorized collector to receive the transfer from ultimate users any unwanted and unused pharmaceutical controlled substances in their lawful possession for safe, secure, and responsible disposal. Any authorized collector must comply fully with the DEA requirements for such an authorized collection program.9.3. Reporting theft of drugs.9.3.1. In the event of any controlled substances being lost or stolen, the registrant shall immediately submit DEA Form 106 to the Board.9.4. Ordering of Controlled Substances. 9.4.1. A registrant shall complete DEA Form 222 for each transfer of a Schedule II controlled substance to another registrant without a prescription.9.4.2. A pharmacist shall verify the receipt within the pharmacy of all controlled substances listed in Schedule II-V by reviewing and countersigning the invoices or packing documents.